These MSCs were engineered by LV infection and designed to conditionally express TNF-related apoptosis inducing ligand (TRAIL), which is a ligand of CD146, to increase the orientation and tropism of MSCs to GBM. The gene discussed is TNFSF10; the disease is infection.